A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection
|Effective start/end date||8/5/21 → 7/31/26|
- NIH NATIONAL CANCER INSTITUTE (NCI)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.